Event Listings
3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA

Be at the forefront of the insights from 60+ leading experts as they share their learnings on:

Commercialization challenges, the payers perspective and the investors’ criteria for business in the current and future NASH market

The non-invasive diagnostics landscape and regulatory considerations on biomarker adoption for clinical trials

Computational methods and artificial intelligence to increase the efficiency of drug development

Scientific rationale of combinational therapeutics as the necessary treatment strategy for NASH to inform pairing decisions

Identification and recruitment of “high risk” patients needed to optimize clinical success and demonstrate sufficient efficacy

Tickets https://go.evvnt.com/296641-0?pid=4870
Brochure https://go.evvnt.com/296641-2?pid=4870

Gold Pass: Full Access (Conference Days + Seminar Day and Discussion Day): USD 4597.0,
Silver Pass: Conference + Seminar Day: USD 3898.0,
Silver Pass: Conference + Discussion Day (2 Workshops): USD 3898.0,
Bronze Pass: Conference Only: USD 2899.0,
Bronze Pass: Seminar Day Only: USD 1399.0,
Bronze Pass: Discussion Day Only (2 Workshops): USD 1399.0

Speakers: Adil Mardinoglu Professor of Systems Biology Kings College London, Allison Capone Global Strategic Marketing for Nonalcoholic Steatohepatitis Intercept, Anthony Samir Assistant Professor Harvard Medical School, Brent Tetri Director, Division of Gastroenterology and Hepatology; Professor of Internal Medicine Saint Louis University School of Medicine, Bryan Burkey Head of Pharmacology Zafgen, Bryan Fuchs Assistant in Molecular Biology Massachusetts General Hospital, Claus Kremoser Chief Executive Officer Phenex Pharmaceuticals, Dean Hum Senior Executive Vice President and Chief Scientific Officer Genfit, Diane Harbison Chief Executive Officer Stratified Medicine Scotland Innovation Centre, David Fraser Chief Scientific Officer NorthSea Therapeutics, Éric Lefebvre Chief Medical Officer Pliant Therapeutics, Etienne Sokal Chief Scientific and Medical Officer Promethera Biosciences, Glenn Rosen Independent Consultant, Greg Everson Chief Executive Officer HepQuant, Greg Tesz Principal Scientist Pfizer, H. James Harwood Adjunct Professor Department of Pathology Wake Forest University School of Medicine, Isai Peimer Biotech Analyst Surveyor Capital, Jagpreet Chhatwal Assistant Professor Harvard Medical School, James Conway Senior Scientist-Translational Bioinformatics MedImmune, Jelena Mann Professor of Epigenetics, Fibrosis Research Group Newcastle University, Jen-Chieh (Jay) Chuang Nonalcoholic Steatohepatitis, Fibrotic Diseases, Biomarker Sciences and Research Scientist Gilead, Jeff Irelan Director, Scientific Application Organovo, Julia Brosnan Senior Director, External Collaborations and Scientific Alliances Pfizer, Katie Brown Vice President, Support and Survivorship Program Lungevity (NASH Patient), Laura Brattain Research Scientist, Department of Radiology Massachusetts General Hospital, Laurent Fischer Senior Vice President Head Liver Therapeutic Area Allergan, Liat Hayardeny Chief Scientific Officer Galmed Pharmaceuticals, Linda Morrow Vice President and Chief Medical Officer ProSciento, Maria-Chiara Magnone Vice President, Metabolic Complications Janssen Research and Development, Marko Korenjak Vice President European Liver Patients Association, Manu Chakravarthy Chief Medical Officer and Senior Vice President Axcella Health, Matthews Bradley Founder, Chairman, President and Chief Technical Officer SAJE Pharma, Min Lu Director, Head of Fibrosis Morphic Therapeutics, Naim Alkhouri Director of the Metabolic Health Center Texas Liver Institute, Nikolai Naoumov Executive Director, Hepatology Sciences and Innovation Novartis, Patrick Horn Chief Medical Officer Albireo Pharmaceuticals, Pascal Prigent Executive Vice President, Commercial Genfit, Peter Guzzo Cofounder and Chief Executive Officer ConSynance Therapeutics, Peter Caravan Director of the Institute for Innovation in Imaging Massachusetts General Hospital, Peter Traber Partner Alacrita Consulting, Pietro Scalfaro Chief Medical Officer Enyo Pharma, Pnina Fishman Chief Executive Officer CanFite BioPharma, Rebecca Taub Chief Medical Officer, Executive Vice President Research and Development Madrigal Pharmaceuticals, Richard Lee Director Ionis Pharmaceuticals, Richard Torstenson Independent Regulatory Advisor, Ritesh Shah Commercial Development Lead, Internal Medicine Pfizer, Robert Arch Executive Director; Head, Liver Disease Program Novartis Institute for BioMedical Research, Roberto Calle Executive Director, Internal Medicine Research Unit Pfizer, Richard Marshall Chief Medical Officer Galecto Biotech, Saswata Talukdar Director – CardioMetabolic Discovery Merck, Saurabh Gupta Director – Translational Research and Early Clinical Takeda, Stephen Previs Director Merck, Suneil Hosmane Executive Vice President- Strategic Development Genfit, Star Seyedkazemi Associate Vice President in Clinical Development Allergan, Wayne Eskridge Chief Executive Officer Fatty Liver Foundation, Weilin Xie Senior Principal Scientist Celgene, Yury Popov Assistant Professor of Medicine Harvard Medical School

Time: 8:00 am - 5:00 pm

Event Date: 22 April 2019 - 25 April 2019 Contact Person: Georgina FitzGerald
Venue: Hilton Boston Logan Airport, 1 Hotel Dr , Boston, MA, 02128 Email:
Country: United States Tel: 617 455 4188

Registration Website: https://go.evvnt.com/296641-1?pid=4870

Submitted by Love Evvnt, Evvnt on Monday, 22 April 2019 at 8:00 AM
Category: Health Care & Medical
Related News

Asthma Therapeutics Market Latest Report with Forecast 2017 - 2025
Thursday, 18 Jul 2019

Winter Tires Market Influenced by Technological Innovation and Consumer Awareness
Wednesday, 17 Jul 2019

Swine Flu Drugs Market Competitive Analysis 2017 to 2025
Wednesday, 17 Jul 2019

Resistant Hypertension Treatment Market : Emerging Trends, Business Growth Opportunities, Major Driv
Wednesday, 17 Jul 2019

Orphan Diseases Testing Market Overview and Regional Outlook Study 2017 – 2025
Wednesday, 17 Jul 2019

Related Events

7th Annual PREDiCT: Tumor Models Boston
Tuesday, 16 Jul 2019

WSAVA Congress & the Canadian Veterinary Medical Association Convention
Tuesday, 16 Jul 2019

4th annual IMPACCT: mHealth in Clinical Trials
Tuesday, 16 Jul 2019

Neurology in Clinical Practice 2019
Thursday, 18 Jul 2019

Current Applications and Future of Artificial Intelligence in Cardiology
Friday, 19 Jul 2019

Upcoming Events

7th Annual PREDiCT: Tumor Models Boston
Tuesday, 16 Jul 2019

WSAVA Congress & the Canadian Veterinary Medical Association Convention
Tuesday, 16 Jul 2019

4th annual IMPACCT: mHealth in Clinical Trials
Tuesday, 16 Jul 2019

Unbound London 2019
Wednesday, 17 Jul 2019

Neurology in Clinical Practice 2019
Thursday, 18 Jul 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Thursday, 18 July 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Latest Press Releases
  • Asthma Therapeutics Market Latest Report with Forecast 2017 - 2025
  • Skyblue Vapor Announces 25% Discounts on its Deluxe Vape Pen Kit
  • Casein Market Share, Size, Growth, Opportunity and Forecast 2019-2024
  • Ethylene Vinyl Acetate Market: Identifies The Key Drivers Of Growth, Challenges & Trends
  • Tips for Choosing the Right Site for Your Refrigerator Filter Needs

  • Latest Jobs
    Sorry, there are currently no entries posted here.